Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum

Journal of Neurochemistry

Volumn 109, Issue 2, 2009, Pages 371-381

  MacCarrone, Mauro ^a,c   De Chiara, Valentina ^b,c   Gasperi, Valeria ^d   Viscomi, Maria Teresa ^c   Rossi, Silvia ^b,c   Oddi, Sergio ^b,c   Molinari, Marco ^c   Musella, Alessandra ^b,c   Finazzi Agrò, Alessandro ^d   Centonze, Diego ^b,c  

^a UNIVERSITY OF TERAMO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

2 arachidonoylglycerol; Anandamide; Cholesterol; Endocannabinoid; GABA transmission; Inhibitory post synaptic current

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINOBUTYRIC ACID; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CHOLESTEROL; DEXANABINOL; ENDOCANNABINOID; FATTY ACID SYNTHASE; METABOTROPIC RECEPTOR 5; METHYL BETA CYCLODEXTRIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; FATTY ACID SYNTHESIS; LIPID METABOLISM; LIPID RAFT; LIPOGENESIS; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR SENSITIVITY; SYNAPTIC TRANSMISSION;

ANIMALS; ARACHIDONIC ACIDS; CHOLESTEROL; CORPUS STRIATUM; ENDOCANNABINOIDS; GLYCERIDES; INHIBITORY POSTSYNAPTIC POTENTIALS; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL;

EID: 62649097236     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.05948.x     Document Type: Article

References (48)

1. Bari M., Battista N., Fezza F., Finazzi-Agrò A. Maccarrone M. (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280, 12212 12220.
2. Bari M., Spagnuolo P., Fezza F., Oddi S., Pasquariello N., Finazzi-Agrò A. Maccarrone M. (2006) Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. J. Immunol. 177, 4971 4980.
3. Bari M., Oddi S., De Simone C., Spagnuolo P., Gasperi V., Battista N., Centonze D. Maccarrone M. (2008) Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology 54, 45 50.
4. Barnett-Norris J., Lynch D. Reggio P. H. (2005) Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. Life Sci. 77, 1625 1639.
5. Becher A., White J.H. McIlhinney R.A. (2001) The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J. Neurochem. 79, 787 795.
6. Beltramo M. Piomelli D. (2000) Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11, 1231 1235.
7. Bisogno T., Maccarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agrò A., Hillard C. Di Marzo V. (2001) The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem. 268, 1982 1989.
8. Bisogno T., Howell F., Williams G. et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463 468.
9. Bonsi P., Cuomo D., De Persis C., Centonze D., Bernardi G., Calabresi P. Pisani A. (2005) Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology 49 (Suppl 1 104 113.
10. Centonze D., Rossi S., Prosperetti C., Tscherter A., Bernardi G., Maccarrone M. Calabresi P. (2005) Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol. Psychiatry 57, 1583 1589.
11. Centonze D., Finazzi-Agrò A., Bernardi G. Maccarrone M. (2007a) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 28, 180 187.
12. Centonze D., Bari M., Rossi S. et al. (2007b) The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 130, 2543 2553.
13. Centonze D., Rossi S., Prosperetti C., Gasperi V., De Chiara V., Bari M., Tscherter A., Febbraro F., Bernardi G. Maccarrone M. (2007c) Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Mol. Cell. Neurosci. 35, 302 310.
14. Cherezov V., Rosenbaum D. M., Hanson M. A. et al. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258 1265.
15. 2-adrenergic receptor reveals important clues for cannabinoid receptors. Cell. Mol. Life Sci. 65, 2277 2279.
16. Di Marzo V., Bisogno T. De Petrocellis L. (2007) Edocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem. Biol. 14, 741 756.
17. Dinh P., Carpenter D., Leslie F. M., Freund T. F., Katona I., Sensi S. L., Kathuria S. Piomelli D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl Acad. Sci. USA 99, 10819 10824.
18. Fezza F., Gasperi V., Mazzei C. Maccarrone M. (2005) Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD) activity. Anal. Biochem. 339, 113 120.
19. Fezza F., Battista N., Bari M. Maccarrone M. (2006) Methods to assay anandamide hydrolysis and transport in synaptosomes. Methods Mol. Med. 123, 163 168.
20. Fourgeaud L., Bessis A. S., Rossignol F., Pin J. P., Olivo-Marin J. C. Hémar A. (2003) The metabotropic glutamate receptor mGluR5 is endocytosed by a clathrin-independent pathway. J. Biol. Chem. 278, 12222 12230.
21. Gajate C. Mollinedo F. (2005) Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J. Biol. Chem. 280, 11641 11647.
22. Gasperi V., Fezza F., Pasquariello N., Bari M., Oddi S., Finazzi-Agrò A. Maccarrone M. (2007) Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cell. Mol. Life Sci. 64, 219 229.
23. Gerdeman G. L., Ronesi J. Lovinger D. M. (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5, 446 451.
24. Hanzal-Bayer M.F. Hancock J.F. (2007) Lipid rafts and membrane traffic. FEBS Lett. 581, 2098 2104.
25. Jung K. M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M., Mackie K. Piomelli D. (2005) Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68, 1196 1202.
26. Katona I., Urbán G. M., Wallace M., Ledent C., Jung K. M., Piomelli D., Mackie K. Freund T. F. (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26, 5628 5637.
27. Lucero H. A. Robbins P. W. (2004) Lipid rafts-protein association and the regulation of protein activity. Arch. Biochem. Biophys. 426, 208 224.
28. Lynch D. L. Reggio P. H. (2006) Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer. J. Comput. Aided Mol. Des. 20, 495 509.
29. Maccarrone M., Barboni B., Paradisi A., Bernabò N., Gasperi V., Pistilli M. G., Fezza F., Lucidi P. Mattioli M. (2005) Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J. Cell Sci. 118, 4393 4404.
30. Maccarrone M., Rossi S., Bari M. et al. (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 11, 152 159.
31. Matyas F., Yanovsky Y., Mackie K., Kelsch W., Misgeld U. Freund T. F. (2006) Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137, 337 361.
32. McFarland M. J., Porter A. C., Rakhshan F. R., Rawat D. S., Gibbs R. A. Barker E. L. (2004) A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J. Biol. Chem. 279, 41991 41997.
33. McFarland M. J., Bardell T. K., Yates M. L., Placzek E. A. Barker E. L. (2008) RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. Mol. Pharmacol. 74, 101 108.
34. Moffett S., Brown D. A. Linder M. E. (2000) Lipid-dependent targeting of G proteins into rafts. J. Biol. Chem. 275, 2191 2198.
35. Oh P. Schnitzer J. E. (2001) Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12, 685 698.
36. Olive M. F., McGeehan A. J., Kinder J. R., McMahon T., Hodge C. W., Janak P. H. Messing R. O. (2005) The mGluR5 antagonist 6-methyl-2-(phenylethynyl) pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol. Pharmacol. 67, 349 355.
37. Piomelli D. (2003) The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4, 873 884.
38. Placzek E. A., Okamoto Y., Ueda N. Barker E. L. (2008) Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. J. Neurochem. 107, 987 1000.
39. Rodgers W., Farris D. Mishra S. (2005) Merging complexes: properties of membrane raft assembly during lymphocyte signaling. Trends Immunol. 26, 97 103.
40. Ronesi J., Gerdeman G. L. Lovinger D. M. (2004) Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J. Neurosci. 24, 1673 1679.
41. Rosenbaum D. M., Cherezov V., Hanson M. A. et al. (2007) GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 318, 1266 1273.
42. Taverna E., Saba E., Rowe J., Francolini M., Clementi F. Rosa P. (2004) Role of lipid microdomains in P/Q-type calcium channel (Cav2.1) clustering and function in presynaptic membranes. J. Biol. Chem. 279, 5127 5134.
43. Taverna E., Saba E., Linetti A., Longhi R., Jeromin A., Righi M., Clementi F. Rosa P. (2007) Localization of synaptic proteins involved in neurosecretion in different membrane microdomains. J. Neurochem. 100, 664 677.
44. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M. Watanabe M. (2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27, 3663 3676.
45. Valenza M. Cattaneo E. (2006) Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list? Prog. Neurobiol. 80, 165 176.
46. Valenza M., Rigamonti D., Goffredo D. et al. (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J. Neurosci. 25, 9932 9939.
47. Wang Y., Liu Y., Ito Y., Hashiguchi T., Kitajima I., Yamakuchi M., Shimizu H., Matsuo S., Imaizumi H. Maruyama I. (2001) Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 294, 73 82.
48. Zamir O. Charlton M. P. (2006) Cholesterol and synaptic transmitter release at crayfish neuromuscular junctions. J. Physiol. 571, 83 99.